46th Annual Health Care Conference on March 2-4, 2026, in Boston, MA29th Annual Scotiabank TMT Conference on March 3-4, 2026, in Toronto, ON38th Annual Roth Conference on March 22-24, 2026, in Dana Point, CAToronto, Ontario--(Newsfile Corp. - February 27, 2026) - HEALWELL AI Inc.(TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, is pleased to announce that Dr. Alexander Dobranowski, President of HEALWELL AI, will be participa ...

Core Insights - HEALWELL AI Inc. has signed its first contract to deliver AI solutions in the Middle East, marking a significant step in its global expansion strategy [1][11] - The company is experiencing continued commercial momentum and adoption of its AI solutions across healthcare systems in North America and now the Middle East [2][4] Global Expansion - Active deployments of HEALWELL's AI solutions now span Canada, the United States, and the Middle East, establishing contracted revenue across multiple healthcare systems [2][11] - The recent success outside of North America validates HEALWELL's strategy of integrating clinically validated AI technology into healthcare software relationships [4][11] AI Solutions Deployment - HEALWELL is deploying core AI solutions such as SMART Identify, SMART Search, and SMART Summary across various healthcare systems, demonstrating platform maturity and scalability [3][12] - The company is embedding AI directly into existing healthcare software and operational workflows, enhancing patient identity management, clinical documentation, and population health analytics [5][11] Leadership Commentary - The CEO of HEALWELL AI highlighted that the last three months have been transformational for the company, emphasizing the success of their strategy in real-time [7] - The company is focused on simplifying its product offerings and building strong momentum for future growth [7] Future Opportunities - HEALWELL reports a growing pipeline of opportunities to expand within existing customers and healthcare systems across multiple regions, including Canada, the United States, Australia, New Zealand, the UK, and the Middle East [6][11]

Core Insights - HEALWELL AI Inc. and WELL Health Technologies Corp. have launched WELLTRUST™, a platform designed for secure, consent-driven patient identification for clinical research within WELL-operated clinics in Canada [1][10]. Company Overview - HEALWELL AI focuses on preventative care through healthcare artificial intelligence, aiming to improve healthcare outcomes by early disease detection and clinical decision support systems [7]. - WELL Health Technologies aims to empower healthcare providers through technology, operating over 240 clinics in Canada and serving more than 43,000 healthcare providers across North America [8]. Platform Features - WELLTRUST accelerates clinical research recruitment by allowing patients to consent to future outreach for clinical trials, combining WELL's clinical footprint with HEALWELL's AI capabilities [2][10]. - The platform provides a privacy-preserving infrastructure that enables ethical patient identification and research acceleration while allowing patients to opt-out if they choose [2][11]. - WELLTRUST includes a robust governance and compliance framework to meet Canadian privacy standards, facilitating partnerships with pharmaceutical sponsors and research organizations [11]. Leadership Commentary - Dr. Alexander Dobranowski from HEALWELL emphasized the platform's commitment to responsible AI in healthcare, aiming to enhance patient access to innovations while maintaining privacy [3]. - Dr. Michael Frankel from WELL highlighted the importance of technology in improving healthcare outcomes and empowering patients to participate in research safely [5].

Core Insights - HEALWELL AI Inc. is making significant strides in integrating its AI capabilities and software platforms, focusing on preventative care and enhancing its SaaS offerings [1][2][8] Integration and Commercial Progress - The company has successfully unified its Khure and Pentavere AI capabilities into a single AI engine powered by DARWEN™, which has improved operational and commercial scale [2][12] - HEALWELL is leveraging Orion Health's global sales distribution network to create new upsell and cross-sell opportunities, enhancing its commercial pipeline as it enters 2026 [2][4] Market Acceptance and Product Development - HEALWELL's AI-enhanced software platforms, including the next-generation Amadeus AI, are gaining traction in markets across Canada, the United States, Europe, and the Middle East [3][12] - The DARWEN™ AI platform continues to expand its disease-state coverage and has received recognition, including the Prix Galien award [5][12] Scientific Validation and Strategic Focus - The company is strengthening its credibility in applied healthcare AI through scientific publications and clinical collaborations, with four publications accepted in the fourth quarter of 2025 [6][12] - HEALWELL is actively pursuing portfolio simplification and evaluating strategic investments, including a $2 million investment in xAI, now part of SpaceX [7][12] Long-term Strategy - The company aims to position itself as a global AI and data science partner for life sciences companies and health systems, capitalizing on structural healthcare tailwinds [8][9]

Core Viewpoint - HEALWELL AI Inc. is clarifying its forward-looking information regarding its strategic divestments and financial performance, emphasizing its transition to a pure-play digital SaaS and AI business focused on health systems and large enterprises globally [1][3]. Financial Performance - The company reported quarterly revenue from continuing operations of $30.4 million in Q3-2025, which annualizes to an approximate revenue run-rate of $120 million, representing a 354% increase compared to revenue of $6.7 million in Q3-2024 [11]. - HEALWELL achieved a positive Adjusted EBITDA of $0.7 million in Q3-2025, compared to an Adjusted EBITDA loss of $2.8 million in Q3-2024, marking the second consecutive quarter of positive Adjusted EBITDA [11]. Strategic Transactions - The November 3rd Release announced the completion of three strategic transactions, including the sale of two non-core businesses and the contribution of two more to a clinical research joint venture, allowing HEALWELL to focus on its core digital SaaS and AI business [3][4]. AI Capabilities and Market Positioning - HEALWELL's AI solutions have received external recognition and validation, particularly through its DARWEN™ AI platform, which specializes in extracting real-world evidence from unstructured clinical data [7][8]. - The company has been recognized for its contributions to healthcare accessibility and preventative care, winning the Prix Galien USA 2024 for Best Digital Health Startup [8]. Research Validation - HEALWELL's AI technologies have been validated through various peer-reviewed studies, demonstrating their effectiveness in automating processes and improving clinical outcomes [12].

Core Insights - HEALWELL AI has appointed Ian Kidson to its Board of Directors to enhance its mission of improving healthcare through early disease identification and detection [1][5] Company Overview - HEALWELL AI Inc. is a healthcare artificial intelligence company focused on preventative care, aiming to save lives through early disease detection [1][6] - The company is publicly traded on the Toronto Stock Exchange under the symbol "AIDX" and on the OTC Exchange under the symbol "HWAIF" [6] Leadership Background - Ian Kidson has extensive experience in both private and public sectors in Canada and the U.S., currently serving on the board of Lakeshore Recycling Systems [2] - He has held significant roles including Chief Financial Officer at Docebo Inc. and Apollo Health Corp., and was Executive Vice President and Chief Financial Officer at Progressive Waste Solutions Ltd. [3] - Kidson's earlier career includes senior leadership positions in capital markets, notably as Managing Director at CIBC Wood Gundy and TD Capital Mezzanine Partners [4] Strategic Importance - The appointment of Ian Kidson is seen as a strategic move to leverage his financial expertise and leadership experience to guide HEALWELL through growth and transformation [5]

Core Insights - HEALWELL AI has completed strategic divestments to transition into a pure-play SaaS, services, and AI business focused on preventative healthcare [3][4][5] - The transactions include the sale of non-core assets to WELL Health Technologies Corp. and the establishment of a clinical research joint venture [3][4][5] Transaction Details - HEALWELL sold its Polyclinic Family Medicine and Specialty Clinics Group to WELL Clinics, which has managed these clinics since January 2024 [5][7] - The company divested its 58.66% interest in Mutuo Health Solutions to WELLSTAR Technologies, allowing HEALWELL to concentrate on its core digital healthcare solutions [5][8] - A 50/50 clinical research joint venture was formed with WELL Health Technologies, aimed at advancing clinical research initiatives [5][9] Financial Impact - The transactions are expected to add approximately $9.4 million in cash to HEALWELL's balance sheet upon closing [4] - HEALWELL's revenue run rate is projected to be around $120 million annually, with profitability on an Adjusted EBITDA basis [5] Strategic Focus - The company aims to enhance its focus on high-margin AI and software services for large enterprise customers globally [4][6] - HEALWELL is committed to integrating validated AI solutions with its healthcare software segment to achieve margin expansion and organic growth [6] Governance and Compliance - A special committee was formed to assess the transactions, ensuring fairness and compliance with regulations [10][11][15] - The transactions were approved under the TSX Company Manual and are exempt from certain formal valuation requirements due to their aggregate fair market value [16][17]

Core Insights - HEALWELL AI and its subsidiary Orion Health have signed a Memorandum of Understanding (MoU) with Lean Business Services to explore digital health and AI solutions in the Middle East and global markets [2][8] - The collaboration aims to enhance population health outcomes and accelerate the adoption of AI in clinical workflows [5][9] Company Overview - HEALWELL AI is focused on preventative care through healthcare artificial intelligence, aiming to improve healthcare and save lives by early disease detection [12] - Lean Business Services is a leading digital health technology company in Saudi Arabia, supporting national digital transformation initiatives and interoperability in healthcare [3][11] - Orion Health specializes in health information exchange technology and has a strong presence in the Middle East, having deployed significant health information exchanges in the region [9] Collaboration Details - The MoU combines HEALWELL's AI capabilities, Lean's market leadership, and Orion Health's interoperability technology to co-develop and commercialize next-generation healthcare solutions [5][8] - Initial collaboration areas include enhancing population health strategies and integrating AI solutions into Saudi Arabia's National Platform for Health and Insurance Exchange Services (NPHIES) [8][9] Strategic Importance - The partnership aligns with Saudi Arabia's Vision 2030 healthcare objectives, aiming to create a connected, data-powered healthcare system [3][7] - The MoU was signed during the Global Health Exhibition in Riyadh, highlighting the significance of this collaboration in advancing healthcare innovation in the region [6][9]

Core Insights - HEALWELL AI will announce its Fiscal Third Quarter 2025 financial results on November 6, 2025, and will hold a conference call on November 7, 2025, at 8:30 AM ET [1][2] Company Overview - HEALWELL AI is a healthcare artificial intelligence company focused on preventative care, aiming to improve healthcare and save lives through early disease identification and detection [3] - The company is developing advanced clinical decision support systems to help healthcare providers detect rare and chronic diseases, enhance practice efficiency, and improve patient health outcomes [3] - HEALWELL AI is publicly traded on the Toronto Stock Exchange under the symbol "AIDX" and on the OTC Exchange under the symbol "HWAIF" [3]

Core Insights - HEALWELL AI Inc. has filed an amended and restated business acquisition report regarding its acquisition of Orion Health Holdings Limited, which was completed on April 1, 2025 [1][2] - The amended report updates the audit report to confirm compliance with International Standards on Auditing (ISA) instead of the previously reported ISA (New Zealand) [2] Company Overview - HEALWELL AI is a healthcare artificial intelligence company focused on preventative care, aiming to improve healthcare through early disease identification and detection [4] - The company is developing advanced clinical decision support systems to assist healthcare providers in detecting rare and chronic diseases, enhancing practice efficiency, and improving patient health outcomes [4] - HEALWELL is publicly traded on the Toronto Stock Exchange under the symbol "AIDX" and on the OTC Exchange under the symbol "HWAIF" [4]